IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
Sushil Kumar(Indian Institute of Science Education and Research, Bhopal), Himanshu Kumar(The University of Osaka)
Cited by 48
Related Papers
Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
|Nature Communications|2021|80
Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways
|Cell Death and Disease|2017|53